Unpacking Averages: Assessing the Racial Composition of Drug Clinical Trial Subjects
Health Law Advisor
FEBRUARY 1, 2022
The United States Food and Drug Administration (FDA) for many years has been trying to increase the participation of minorities in clinical trials to help ensure that regulated products are tested and labeled in an appropriate cross-section of Americans. National Library of Medicine, with support from FDA.
Let's personalize your content